Form 4: Agilent Technologies Executive Rodney Gonsalves Reports Stock Sale and Dividend Reinvestment

Sentiment:

SEC Form 4 Filing


Rodney Gonsalves, V.P., Corporate Controller at Agilent Technologies, reports the sale of 4,828 shares of common stock and acquisition of 24.491 shares through a dividend reinvestment plan.

Summary

  • Rodney Gonsalves, a V.P., Corporate Controller at Agilent Technologies, filed a Form 4 detailing changes in beneficial ownership.
  • On March 7, 2024, Gonsalves sold 4,828 shares of Agilent Technologies common stock at a price of $148.995 per share.
  • On March 7, 2024, Gonsalves acquired 24.491 shares through the Agilent Technologies, Inc. dividend reinvestment plan.
  • Following these transactions, Gonsalves directly owns 21,329.4748 shares of common stock.
  • Gonsalves also indirectly owns 40.192 shares through the Gonsalves Trust, for which he and Rochelle Gonsalves are trustees.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their potential impact on stock prices. This filing indicates normal trading activity by an executive.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders, but the dividend reinvestment could be seen as a positive sign.

Key Dates

DateDescription
03/07/2024Date of stock sale and dividend reinvestment.
03/08/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.